Comparative Study of the Antithrombotic Effects of Ticagrelor and Clopidogrel in Type 2 Diabetic Patients
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease; Thrombosis
- Focus Therapeutic Use
- 24 Aug 2017 Results published in the Thrombosis and Haemostasis
- 13 Apr 2016 Status changed from recruiting to completed.
- 05 May 2015 Planned End Date changed from 1 May 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.